Dermatologic Consequences of Substandard,Spurious, Falsely Labeled,Falsified, and Counterfeit Medications |
| |
| Institution: | 1. Department of Dermatology, George Washington University School of Medicine and Health Sciences, 2150 Pennsylvania Ave, NW, Suite 2B-430, Washington, DC 20037, USA;2. Georgetown University School of Medicine, Washington, DC, USA;3. University of North Carolina School of Medicine, Chapel Hill, NC, USA;4. Department of Dermatology, Johns Hopkins Medicine, Baltimore, MD, USA;1. Penn State College of Medicine, Penn State Hershey Medical Center, Penn State University, Hershey, Pennsylvania;2. Department of Dermatology, Penn State Hershey Medical Center, Penn State University, Hershey, Pennsylvania;1. Albany Medical College, Albany, New York;2. Department of Dermatology, University of California, Irvine, California;3. Department of Dermatology, Center for Cutaneous Oncology, Dana-Farber/Brigham and Women''s Cancer Center, Boston, Massachusetts;4. Department of Dermatology, Brigham and Women''s Hospital, Boston, Massachusetts;5. Department of Dermatology, Loma Linda University, Loma Linda, California;1. Penn State/ Hershey Medical Center, Department of Dermatology, 500 University Drive, Hershey, PA 17033, USA;2. Penn State College of Medicine, 500 University Drive, Hershey, PA 17033, USA;3. Penn State/ Hershey Medical Center, Departments of Dermatology and Pediatrics, 500 University Drive, Hershey, PA 17033, USA |
| |
| Abstract: | |
| |
| Keywords: | Counterfeit drugs Drug eruptions Substandard drugs Fraud Crime Pharmaceutical preparations |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
